As fears mount about a possible world bird flu epidemic, the maker of antiviral drug Tamiflu has agreed to help generic pharmaceutical manufacturers increase production of the medicine.
Tamiflu, which is made by Swiss pharmaceutical giant Roche, is the leading anti-flu drug on the market. Countries have spent billions stockpiling the drug after the World Health Organisation issued a warning on the possibility of a flu pandemic caused by the avian flu, the H5N1 virus....
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team